Fingolimod
74 interactions 5 explained in plain EnglishFingolimod is a sphingosine-1-phosphate receptor modulator used to reduce relapses and slow disability worsening in relapsing-remitting multiple sclerosis. Read the full Fingolimod drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Fingolimod Granisetron Transdermal Patch Sancuso Increased risk of QT interval prolongation Details Fingolimod Granisetron Injection Granisol Increased risk of QT interval prolongation Details Fingolimod Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Fingolimod Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Fingolimod Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Fingolimod Ivabradine Corlanor Increased risk of QT prolongation Details Fingolimod Ketoconazole Topical Extina® Foam Increased fingolimod exposure and an increased risk of QT interval prolongation Details Fingolimod Labetalol Normodyne® Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Lefamulin Xenleta Increased risk of QT interval prolongation Details Fingolimod Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Fingolimod Levobunolol Ophthalmic AKBeta® Severe bradycardia or heart block Details Fingolimod Levofloxacin Levaquin Increased risk of QT interval prolongation Details Fingolimod Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Fingolimod Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Fingolimod Mefloquine Lariam® Increased risk of QT interval prolongation Details Fingolimod Metronidazole Flagyl An increased risk of QT interval prolongation Details Fingolimod Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Fingolimod Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Fingolimod Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Fingolimod Moxifloxacin Avelox Increased risk of QT interval prolongation Details Fingolimod Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Fingolimod Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Fingolimod Nadolol Corgard Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Nebivolol Bystolic Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Octreotide Bynfezia Increased risk of QT interval prolongation Details Fingolimod Octreotide Injection Bynfezia Increased risk of QT interval prolongation Details Fingolimod Ofloxacin Floxin® Increased risk of QT interval prolongation Details Fingolimod Ofloxacin Ophthalmic Ocuflox Increased risk of QT interval prolongation Details Fingolimod Ofloxacin Otic Floxin® Otic Increased risk of QT interval prolongation Details Fingolimod Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Fingolimod Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details Fingolimod Penbutolol Levatol® Severe bradycardia or heart block DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist